Combined ablation for paroxysmal atrial fibrillation and drug-refractory hypertrophic obstructive cardiomyopathy: a case report. 2021

Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu-city, Shizuoka 431-3192, Japan.

BACKGROUND Hypertrophic obstructive cardiomyopathy (HOCM) is sometimes concomitant with atrial fibrillation (AF) and exacerbates heart failure symptoms. Although optimal medication for the reduction of left ventricular outflow tract (LVOT) obstruction and the maintenance of sinus rhythm should be considered, it is difficult to control the symptoms permanently. METHODS A 45-year-old man, diagnosed with HOCM, presented with progressive dyspnoea on exertion, which significantly deteriorated during episodes of paroxysmal AF, despite optimal medical therapy. On echocardiography, we found LVOT obstruction with a peak pressure gradient of 98 mmHg, concomitant with redundant mitral valve leaflets, which caused significant systolic anterior motion (SAM). Since he declined open surgery, we selected a combination of catheter interventions, AF ablation, and alcohol septal ablation (ASA). After the AF ablation, the occurrence of AF significantly decreased, and there was no recurrence after the ASA. By 6 months, the plasma N-terminal pro-B-type natriuretic peptide level had decreased from 1022 to 124 pg/mL, the peak pressure gradient of LVOT decreased from 98 to 12 mmHg, and the left atrium volume decreased from 203 to 178.4 mL. The improvement in the SAM was visualized on echocardiography and was haemodynamically corroborated by the four-dimensional (4D)-flow cardiac magnetic resonance (CMR). CONCLUSIONS The treatment of drug-refractory HOCM concomitant with paroxysmal AF needs both septal reduction and the maintenance of sinus rhythm, which can be accomplished through transcatheter interventions. Moreover, the detailed intra-ventricular haemodynamic assessment in HOCM patients can be explored using the 4D-flow CMR.

UI MeSH Term Description Entries

Related Publications

Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
October 2022, The Journal of international medical research,
Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
January 2009, Journal of atrial fibrillation,
Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
September 2000, International journal of cardiology,
Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
January 1983, Annales de medecine interne,
Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
April 2018, The Journal of thoracic and cardiovascular surgery,
Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
November 1999, Journal of cardiology,
Keitaro Akita, and Kenichiro Suwa, and Tsuyoshi Urushida, and Yuichiro Maekawa
March 2006, Heart rhythm,
Copied contents to your clipboard!